Literature DB >> 4019023

HPLC-studies on nonmercapt-mercapt conversion of human serum albumin.

M Sogami, S Era, S Nagaoka, K Kuwata, K Kida, K Miura, H Inouye, E Suzuki, S Hayano, S Sawada.   

Abstract

Human mercaptalbumin (HMA) and nonmercaptalbumin (HNA) could be separated by high-performance liquid chromatography (HPLC) at neutral pH. Using HPLC, the present authors found the nonmercapt-mercapt conversion (HNA----HMA) during hemodialysis and the mercapt-nonmercapt conversion (HMA----HNA) after hemodialysis in chronic renal failure, indicating HMA as the covalent carrier protein for sulfur-containing amino acids.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4019023     DOI： 10.1111/j.1399-3011.1985.tb02191.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN： 0367-8377


  11 in total

1.  Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation.

Authors:  Kazumasa Aoyagi
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

2.  A lower level of reduced albumin induces serious cardiovascular incidence among peritoneal dialysis patients.

Authors:  Hiroyuki Terawaki; Yukie Matsuyama; Nanae Matsuo; Makoto Ogura; Jun Mitome; Akihiko Hamaguchi; Tomoyoshi Terada; Seiichi Era; Tatsuo Hosoya
Journal:  Clin Exp Nephrol       Date:  2012-02-23       Impact factor: 2.801

3.  Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo.

Authors:  Makoto Anraku; Ulrich Kragh-Hansen; Keiichi Kawai; Toru Maruyama; Yasuomi Yamasaki; Yoshinobu Takakura; Masaki Otagiri
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

4.  Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: reduced albumin might participate in redox regulation of nerve and blood vessel systems.

Authors:  Yukie Matsuyama; Tomoya Hayashi; Hiroyuki Terawaki; Tsuneo Negawa; Tomoyoshi Terada; Yukio Okano; Seiichi Era
Journal:  J Physiol Sci       Date:  2009-03-10       Impact factor: 2.781

5.  Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease.

Authors:  Yukie Matsuyama; Hiroyuki Terawaki; Tomoyoshi Terada; Seiichi Era
Journal:  Clin Exp Nephrol       Date:  2009-04-11       Impact factor: 2.801

6.  Oxidized human serum albumin as a possible correlation factor for atherosclerosis in a rural Japanese population: the results of the Yakumo Study.

Authors:  Ryosuke Fujii; Jun Ueyama; Arisa Aoi; Naohiro Ichino; Keisuke Osakabe; Keiko Sugimoto; Koji Suzuki; Nobuyuki Hamajima; Kenji Wakai; Takaaki Kondo
Journal:  Environ Health Prev Med       Date:  2018-01-02       Impact factor: 3.674

7.  Comparison of quality of human serum albumin preparations in two pharmaceutical products.

Authors:  Hajime Nakae; Kouki Tomida; Yoshihiro Kikuya; Manabu Okuyama; Toshiko Igarashi
Journal:  Acute Med Surg       Date:  2017-03-01

8.  Evaluation of human nonmercaptalbumin as a marker for oxidative stress and its association with various parameters in blood.

Authors:  Rie Masudo; Keiko Yasukawa; Takahiro Nojiri; Naoyuki Yoshikawa; Hironori Shimosaka; Shinji Sone; Yumiko Oike; Akemi Ugawa; Tsutomu Yamazaki; Kentaro Shimokado; Yutaka Yatomi; Hitoshi Ikeda
Journal:  J Clin Biochem Nutr       Date:  2017-07-20       Impact factor: 3.114

9.  Serum oxidized albumin and cardiovascular mortality in normoalbuminemic hemodialysis patients: a cohort study.

Authors:  Paik Seong Lim; Yachung Jeng; Ming Ying Wu; Mei-Ann Pai; Tsai-Kun Wu; Chia-San Liu; Chan Hsu Chen; Yuan-Chuan Kuo; Shiaw-Wen Chien; Hung Ping Chen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Structural and functional insights into S-thiolation of human serum albumins.

Authors:  Fumie Nakashima; Takahiro Shibata; Kohei Kamiya; Jun Yoshitake; Ryosuke Kikuchi; Tadashi Matsushita; Isao Ishii; Juan A Giménez-Bastida; Claus Schneider; Koji Uchida
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.